Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

Affiliations

• ¹ The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
• ³ Harvard Medical School, Boston, Massachusetts, USA.
• ⁴ Graduate Program in Cell and Molecular Physiology, Sackler School of Graduate Biomedical Sciences, School of Medicine, Tufts University, Boston, Massachusetts, USA.
• ⁵ Department of Surgical Oncology, Medical Oncology and Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
• ⁶ The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Levi_Garraway@dfci.harvard.edu.
• ⁷ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Levi_Garraway@dfci.harvard.edu.
• ⁸ Harvard Medical School, Boston, Massachusetts, USA. Levi_Garraway@dfci.harvard.edu.